Tag: crispr

Translational Regenerative Medicine market is estimated to grow at a CAGR of 24.3% by 2034: Visiongain

Visiongain Reports Ltd Visiongain has published a new report entitled: Translational Regenerative Medicine Market Report 2024-2034: Forecasts by Product (Stem Cell Therapy (Autologous, Allogenic), Tissue Engineering (Scaffold, Hydrogels), Gene Therapy, Others)), by Application (Oncology, Dermatology, Musculoskeletal, Neurology, Cardiovascular, Wound Healing, Ophthalmology, Others) AND Regional and Leading National Market Analysis PLUS…

Continue Reading Translational Regenerative Medicine market is estimated to grow at a CAGR of 24.3% by 2034: Visiongain

Translational Regenerative Medicine market is estimated to

Visiongain has published a new report entitled: Translational Regenerative Medicine Market Report 2024-2034: Forecasts by Product (Stem Cell Therapy (Autologous, Allogenic), Tissue Engineering (Scaffold, Hydrogels), Gene Therapy, Others)), by Application (Oncology, Dermatology, Musculoskeletal, Neurology, Cardiovascular, Wound Healing, Ophthalmology, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading…

Continue Reading Translational Regenerative Medicine market is estimated to

Preparation and recognition mechanism study of an scFv targeting chloramphenicol for a hybridization chain reaction-CRISPR/Cas12a amplified fluoroimmunoassay

. 2024 Mar 8:1293:342283. doi: 10.1016/j.aca.2024.342283. Epub 2024 Jan 22. Affiliations Expand Affiliations 1 College of Food Science and Technology, Hebei Agricultural University, Baoding, 071001, China. 2 Medical College, Nankai University, Tianjin, 300500, China. Electronic address: wangshuo@nankai.edu.cn. 3 College of Food Science and Technology, Hebei Agricultural University, Baoding, 071001, China….

Continue Reading Preparation and recognition mechanism study of an scFv targeting chloramphenicol for a hybridization chain reaction-CRISPR/Cas12a amplified fluoroimmunoassay

The woman behind the genomic scissors CRISPR-Cas9 :: Understanding Animal Research

For this year’s women and girls in science day, UAR chose to highlight the career of a world-renowned scientist and how animal research shaped her path to becoming one of the most respected and revered researchers. Working in fundamental science and microbiology, Emmanuelle Charpentier gradually obtained prizes, eventually receiving one…

Continue Reading The woman behind the genomic scissors CRISPR-Cas9 :: Understanding Animal Research

Functional genomic screening in Komagataella phaffii enabled by high-activity CRISPR-Cas9 library

Abstract CRISPR-based high-throughput genome-wide loss-of function screens are a valuable approach to functional genetics and strain engineering. The yeast Komagataella phaffii is a host of particular interest in the biopharmaceutical industry and as a metabolic engineering host for proteins and metabolites. Here, we design and validate a highly active 6-fold…

Continue Reading Functional genomic screening in Komagataella phaffii enabled by high-activity CRISPR-Cas9 library

CRISPR/Cas9 are the Most Sought Genome Editing Tools

Company Logo Global Genome Editing Market Global Genome Editing Market Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) — The “Global Genome Editing Market, 2023-2035: Focus on Technology, Industry Trends and Forecasts” report has been added to ResearchAndMarkets.com‘s offering. The global genome editing market size for technologies is estimated to be worth…

Continue Reading CRISPR/Cas9 are the Most Sought Genome Editing Tools

All Roads Lead to Genome Editing

Shondra Pruett-Miller, a biochemist at St. Jude Children’s Research Hospital, found her calling during her first year of graduate school at the University of Texas, Southwestern. In 2003, during the departmental faculty research talks, she watched with excitement as Matthew Porteus, now a biochemist at Stanford University, presented his research…

Continue Reading All Roads Lead to Genome Editing

Author Correction: Prime editing using CRISPR-Cas12a and circular RNAs in human cells

New Cornerstone Science Laboratory, Center for Genome Editing, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China Ronghong Liang, Zixin He, Haocheng Zhu, Jiacheng Hu, Guanwen Liu, Meiyan Liu, Rui Zhang & Caixia Gao College of Advanced Agricultural Sciences, University of Chinese Academy of Sciences, Beijing, China Zixin He, Haocheng Zhu, Meiyan Liu & Caixia Gao Qi Biodesign, Beijing,…

Continue Reading Author Correction: Prime editing using CRISPR-Cas12a and circular RNAs in human cells

How the Quantum World Can Help Scientists Engineer Biology

The Science Newswise — CRISPR-Cas is a tool that allows scientists to make targeted changes to an organism’s DNA. This tool consists of two parts. The first is a microscopic substance called a nuclease Cas protein (e.g., Cas9) that can cleave DNA. The second is an RNA molecule (also called…

Continue Reading How the Quantum World Can Help Scientists Engineer Biology

ZsGreen/Luciferase Safe-Harbor HEK293 Cell Line | BPS Bioscience

Product information “ZsGreen/Luciferase Safe-Harbor HEK293 Cell Line” Recombinant stable HEK293 cell line constitutively expressing ZsGreen (bright green fluorescent protein derived from Zoanthus sp. reef coral) and firefly luciferase, which have been stably integrated into the AAVS1 safe harbor locus on chromosome 19 using CRISPR/Cas9. Expression of ZsGreen and the luciferase…

Continue Reading ZsGreen/Luciferase Safe-Harbor HEK293 Cell Line | BPS Bioscience

Treating the Untreatable with Precision Therapies – A $4 trillion Opportunity?

Precision Therapies For Targeted Results Precision therapies have always been the ultimate goal of medicine. Instead of drugs acting on multiple parts of the body, these therapies would only target one organ, one cell, or even one gene. In theory, not only would this be a lot more efficient, but…

Continue Reading Treating the Untreatable with Precision Therapies – A $4 trillion Opportunity?

Better Strawberries Thanks to CRISPR Breakthrough

Netherlands-based company announces the inaugural regeneration of strawberries from gene-edited individual cells. Hudson River Biotechnology (HRB), headquartered in Wageningen, The Netherlands, announced the first successful regeneration of strawberry plants from gene-edited single cells, utilizing its unique CRISPR technology known as TiGER. The berry industry is currently facing challenges, transitioning from…

Continue Reading Better Strawberries Thanks to CRISPR Breakthrough

2023 gene therapy research STAR Grant winners announced

At PacBio, enabling the promise of genomics to better human health cuts right to the core of everything we do.That’s why in 2023 we created the STAR (Student Travel Awarded Researcher) Grant program. This exciting funding opportunity is intended to assist up-and-coming researchers in genomics-aligned fields with sequencing services and…

Continue Reading 2023 gene therapy research STAR Grant winners announced

Gene editing biotech Metagenomi prices IPO at $15, the low end of the range

Metagenomi, a preclinical biotech using metagenomics-derived genome editing, raised $94 million by offering 6.3 million shares at $15, the low end of the range of $15 to $17. Metagenomi is a precision genetic medicines company developing curative therapeutics using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Its toolbox includes…

Continue Reading Gene editing biotech Metagenomi prices IPO at $15, the low end of the range

5 hot biotechnology careers skyrocketing in demand

With many exciting discoveries to make and new problems to solve, the biotechnology industry provides many career opportunities that could make a difference in people’s lives. So, if you are searching for a career in the field, we have listed five biotechnology careers that are currently in high demand, and…

Continue Reading 5 hot biotechnology careers skyrocketing in demand

what will therapy look like in 2034?

Drugs like PARP inhibitors and chimeric antigen receptor (CAR) therapies, and advancements in artificial intelligence in drug discovery, have spurred hope for improved cancer care in the past year. Rigorous research has paved the way for a declining cancer death rate – by 33% to be precise – since the…

Continue Reading what will therapy look like in 2034?

Twisted DNA Increases CRISPR Off-target Effects

At the end of 2023, the FDA approved Casgevy for sickle cell disease, its first approval for a therapeutic that used the genome editing tool clustered regulatory interspaced palindromic repeats (CRISPR) to specifically inactivate a human gene as a treatment for a genetic disease. While CRISPR-based gene therapies could potentially…

Continue Reading Twisted DNA Increases CRISPR Off-target Effects

16 UK biotech companies you should know about

The UK is home to several biotech hubs, including the famous ‘golden triangle’, made up of Oxford, Cambridge, and London. In fact, after a $700 million surge in funding in the third quarter of 2023, the UK biotech scene is now one of the most vibrant in Europe, laying the…

Continue Reading 16 UK biotech companies you should know about

Advancements in CRISPR-Based Pathogen Detection: Limitations and Recent Progress

Gene editing technologies, particularly those based on Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), have revolutionized our ability to accurately and swiftly detect pathogens. However, even these advanced methods have their limitations. This article explores these limitations and highlights recent advancements that are paving the way for faster, more accurate…

Continue Reading Advancements in CRISPR-Based Pathogen Detection: Limitations and Recent Progress

Biotech job market 2024: what to expect?

The past year saw a string of pipeline cuts and downsizing plans strike the biotech job market. Have layoffs spooked young professionals looking for a way into the industry, and does the employment landscape seem to be looking up this year? Employment in the life sciences industry had hit a…

Continue Reading Biotech job market 2024: what to expect?

CRISPR Off-target Sequencing for Agriculture

CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR-associated protein) genome editing enables precise, targeted genetic modification of plants. To date, the genomes of several crops, including rice, tomato, corn, wheat, soybean, barley, potato, sorghum, apple, grapefruit, and orange, have been edited using CRISPR-Cas-based genome editing technology. The CRISPR system cuts not…

Continue Reading CRISPR Off-target Sequencing for Agriculture

Structure-guided discovery of anti-CRISPR and anti-phage defense proteins

Identification of putative anti-crispr proteins using structural features To identify Acrs in phage genomes, we began by retrieving ~66.5 million proteins from Integrated Microbial Genomes Virus database (IMG/VR)37. We excluded large proteins because over 90% of known Acrs contain less than 200 amino acids38 (Fig. 1A, Supplementary Data 1). To reduce computational…

Continue Reading Structure-guided discovery of anti-CRISPR and anti-phage defense proteins

Two Million Cancers; Casgevy OK’d for Thalassemia; Rectal Exams and Prostate Cancer

While cancer mortality continues to decline, the number of new cases is projected to top 2 million in 2024, according to the American Cancer Society’s annual report on cancer statistics. The FDA approved exagamglogene autotemcel (Casgevy) for transfusion-dependent beta thalassemia in patients 12 years and older, maker Vertex announced. This…

Continue Reading Two Million Cancers; Casgevy OK’d for Thalassemia; Rectal Exams and Prostate Cancer

Path to Safer Genome Engineering: CRISPR Off-Switches?

Using CRISPR, an immune system bacteria use to protect themselves from viruses, scientists have harnessed the power to edit genetic information within cells. In fact, the first CRISPR-based therapeutic was recently approved by the FDA to treat sickle cell disease in December 2023. That therapy is based on a highly…

Continue Reading Path to Safer Genome Engineering: CRISPR Off-Switches?

(Open Access) A simple approach for multi-targeted shRNA-mediated inducible knockdowns using Sleeping Beauty vectors. (2018) | Severin Fink

Abstract: It is estimated that only 0.02% of disseminated tumor cells are able to seed overt metastases1. While this indicates the presence of environmental constraints to metastatic seeding, the landscape of host factors controlling this process remains largely unknown. Combining transposon technology2 and fluorescent niche labeling3, we developed an in…

Continue Reading (Open Access) A simple approach for multi-targeted shRNA-mediated inducible knockdowns using Sleeping Beauty vectors. (2018) | Severin Fink

Study of CRISPR-Cas3 brings us a step closer

 Cornell researchers have taken an important step toward harnessing CRISPR gene editing in “targeted, safe and potent” cancer treatment, according to Ailong Ke, professor of chemistry and chemical biology in the College of Arts and Sciences. The enzyme CRISPR-Cas3, one of many different CRISPR systems found naturally in the immune systems…

Continue Reading Study of CRISPR-Cas3 brings us a step closer

Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly

Capturing proteins associated with SARS-CoV-2 virions To identify host cell proteins potentially present in extracellular SARS-CoV-2 virions, viral particles were produced from two lung epithelial cell models, A549 cells overexpressing ACE2 receptor (A549-ACE2) and Calu-3 cells that naturally express ACE2 receptor and TMPRSS2. Following infection with the D614G SARS-CoV-2 strain32,…

Continue Reading Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly

The Role of Nanoparticles in Cancer Therapy: Advancements in Nanotechnology

With the advent and advancements in nanotechnology, the field of cancer therapy is witnessing a paradigm shift. Nanoparticles, owing to their unique properties, are proving to be promising carriers for drug delivery in cancer therapy. The study scrutinizes the transport of nanoparticles in two abnormal microenvironments through a 2-D simulation…

Continue Reading The Role of Nanoparticles in Cancer Therapy: Advancements in Nanotechnology

Week 7 Discussion (docx) – Course Sidekick

Option 2: Genetics is a rapidly evolving area of science. Each year, advances in genetics bring exciting new technologies to the market. Areas such as forensics, genealogy, and healthcare have all been affected by new genetic technologies. Choose a genetic technology and report on how this technology is affecting or…

Continue Reading Week 7 Discussion (docx) – Course Sidekick

CRISPR off-switches: A path towards safer gen

Using CRISPR, an immune system bacteria use to protect themselves from viruses, scientists have harnessed the power to edit genetic information within cells. In fact, the first CRISPR-based therapeutic was recently approved by the FDA to treat sickle cell disease in December 2023. That therapy is based on a highly…

Continue Reading CRISPR off-switches: A path towards safer gen

could it be a cure?

When CASGEVY, the first CRISPR-based therapy, was approved by the FDA in December, it gave CRISPR technology the validation it needed. Any promise it had held before that moment was simply investigational. In this case, the approval of CASGEVY was granted for the treatment of two blood disorders – sickle…

Continue Reading could it be a cure?

Genetic Frontiers: Ethical Dilemmas in the Age of CRISPR | by Amy Belluomini | Jan, 2024

Photo by Sangharsh Lohakare on Unsplash In the landscape of scientific advancement, the emergence of CRISPR technology has propelled humanity into a new era of genetic possibilities. While the revolutionary gene-editing tool offers unprecedented opportunities to reshape the blueprint of life, it also raises profound ethical dilemmas that echo through…

Continue Reading Genetic Frontiers: Ethical Dilemmas in the Age of CRISPR | by Amy Belluomini | Jan, 2024

Restriction Enzyme Market is set to Reach US$ 647.41 million at a CAGR of 5.7% from the forecast period 2023 to 2031

Growth Plus Reports Pune, Jan. 08, 2024 (GLOBE NEWSWIRE) — According to the latest report published by Growth Plus Reports, the global Restriction Enzyme Market is expected to clock US$ 647.41 million by 2031 and to grow at a CAGR of 5.7% during the forecast period. The Restriction Enzyme Market…

Continue Reading Restriction Enzyme Market is set to Reach US$ 647.41 million at a CAGR of 5.7% from the forecast period 2023 to 2031

miR-195b is required for proper cellular homeostasis in the elderly

Expression pattern of miR-195 during embryonic development We analyzed the expression pattern of miR-195 by in situ hybridization at two distinct developmental stages in mouse embryos. Whole-mount in situ hybridization at E10.5, demonstrated a wide expression of miR-195 along the entire embryo, including the central nervous system, the cardiopharyngeal area,…

Continue Reading miR-195b is required for proper cellular homeostasis in the elderly

CRISPR/Cas12a linked sandwich aptamer assay for sensitive detection of thrombin

Background: Thrombin is a serine protease and hemostasis regulator with multiple functions and recognized as an important biomarker for diseases, and sensitive detection of thrombin is of significance for clinical diagnostics and disease monitoring. Recently, the target-triggered nonspecific single-stranded deoxyribonuclease activity of CRISPR/Cas system is discovered, making it become a…

Continue Reading CRISPR/Cas12a linked sandwich aptamer assay for sensitive detection of thrombin

2 low-priced gene therapy stocks to speculate on

Key Points bluebird bio has three FDA-approved gene therapy treatments that are planning to commercialize after its $150 million secondary offering of common shares priced at $1.50 per share. bluebird bio’s latest FDA approval, LYFGENIA, is a one-time treatment for sickle cell disease, which is priced around $3.1 million per…

Continue Reading 2 low-priced gene therapy stocks to speculate on

Rolling circle amplification assisted CRISPR/Cas12a dual-cleavage photoelectrochemical biosensor for highly sensitive detection of miRNA-21

Background: MicroRNA-21 has been determined to be the only microRNA overexpressed in 11 types of solid tumors, making it an excellent candidate as a biomarker for disease diagnosis and therapy. Photoelectrochemical (PEC) biosensors have been widely used for quantification of microRNA-21. However, most PEC biosensing processes still suffer from some…

Continue Reading Rolling circle amplification assisted CRISPR/Cas12a dual-cleavage photoelectrochemical biosensor for highly sensitive detection of miRNA-21

Restriction Enzyme Market is set to Reach US$ 647.41

Pune, Jan. 08, 2024 (GLOBE NEWSWIRE) — According to the latest report published by Growth Plus Reports, the global Restriction Enzyme Market is expected to clock US$ 647.41 million by 2031 and to grow at a CAGR of 5.7% during the forecast period. The Restriction Enzyme Market is witnessing significant…

Continue Reading Restriction Enzyme Market is set to Reach US$ 647.41

Sox2 Gene Enhancers: Unraveling Cancer’s Genetic Secrets

Unveiling Cancer’s Genetic Mechanisms: Role of Sox2 Gene Enhancers In a groundbreaking study led by Professor Jennifer Mitchell at the University of Toronto’s Department of Cell and Systems Biology, vital insights were garnered on the role of ‘enhancer’ regions in gene expression and their implications for cancer growth. Enhancers, non-coding…

Continue Reading Sox2 Gene Enhancers: Unraveling Cancer’s Genetic Secrets

Global Genome Editing Market Exhibits Robust Growth Amid Therapeutic Advances And Agricultural Biotechnology Expansion

(MENAFN– PR Newswire) DUBLIN, Jan. 8, 2024 /PRNewswire/ — The “Genome Editing Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F” report has been added to ResearchAndMarkets’s offering. The transformative power of genome editing continues to spur significant growth in the biotechnology sector, with the Global Genome Editing…

Continue Reading Global Genome Editing Market Exhibits Robust Growth Amid Therapeutic Advances And Agricultural Biotechnology Expansion

CRISPR Therapeutics Highlights Strategic Priorities and

ZUG, Switzerland and BOSTON, Jan. 08, 2024 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and 2024 outlook as the Company enters its next phase of growth. “We had a landmark year in 2023, marked…

Continue Reading CRISPR Therapeutics Highlights Strategic Priorities and

The best countries for biotech according to the OECD

The OECD recently published an update on key biotechnology indicators, an opportunity for us to delve into the top-performing countries in the field. With the highest number of active biotech companies (2,840) and an R&D intensity added value of 17%, the U.S. remains a strong leader in the industry. But…

Continue Reading The best countries for biotech according to the OECD

Revolutionizing acne treatment with CRISPR technology

Eligo Bioscience is a gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, and in its crosshairs, initially, is moderate to severe acne vulgaris, an inflammatory disease that affects about 3% of the global population. This week, we talk to Xavier Duportet, CEO…

Continue Reading Revolutionizing acne treatment with CRISPR technology

Crispr Library Download

CRISPR guide RNA libraries have been iteratively improved to provide increasingly efficient reagents, although their large size is a barrier for many applications. We design an optimised minimal genome-wide human CRISPR-Cas9 library (MinLibCas9) by mining existing large-scale gene loss-of-function datasets, resulting in a greater than 42% reduction in size compared…

Continue Reading Crispr Library Download

Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) market 2023-2030

Market Overview The Middle East and Africa (MEA) region is witnessing significant advancements in the field of regenerative medicine, particularly in the area of induced pluripotent stem cells (iPSCs). iPSCs are derived from adult cells and possess the remarkable ability to differentiate into various cell types, making them a valuable…

Continue Reading Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) market 2023-2030

Biophysical Society names fellows

Rommie Amaro Ivet Bahar Jennifer Doudna The Biophysical Society has named seven 2024 society fellows, and three of them are members of the American Society for Biochemistry and Molecular Biology: Rommie Amaro, Ivet Bahar and Jennifer Doudna. Amaro is a professor and endowed chair in the molecular biology department and…

Continue Reading Biophysical Society names fellows

Science and technology trends that defined 2023

The year 2023 has been marked by significant advancements and breakthroughs in science and technology. From AI and quantum computing to genomic medicine and renewable energy, emerging technologies have reshaped various industries. With trends like the metaverse and advancements in space exploration, the future looks promising for continued progress and…

Continue Reading Science and technology trends that defined 2023

Knockout of lipoprotein lipase with CRISPR/Cas9 causes severe developmental defects and affects lipid deposition in Japanese medaka (Oryzias latipes)

Abstract In mammals, lipoprotein lipase (LPL) has been found to play an important role in lipid mentalism and deposition. LPL deficiency in humans (Homo sapiens) and mice (Mus musculus) tends to cause hypertriglyceridemia. The lpl gene is not expressed in adult mammalian liver, but is in adult fish liver. The…

Continue Reading Knockout of lipoprotein lipase with CRISPR/Cas9 causes severe developmental defects and affects lipid deposition in Japanese medaka (Oryzias latipes)

CRISPR-Cas12a base editors confer efficient multiplexed genome editing in rice.

Addgene: CRISPR-Cas12a base editors confer efficient multiplexed genome editing in rice. More than 20 requests More than 50 requests More than 100 requests Item added to cart. Cart quantity updated. Limit per order. Item already in cart. Could not add item to cart. Skip to main content CRISPR-Cas12a base editors…

Continue Reading CRISPR-Cas12a base editors confer efficient multiplexed genome editing in rice.

Low dose ribosomal DNA P-loop mutation affects development and enforces autophagy in Arabidopsis

Arabidopsis contains hundreds of ribosomal DNA copies organized within the nucleolar organizing regions (NORs) in chromosomes 2 and 4. There are four major types of variants of rDNA, VAR1–4, based on the polymorphisms of 3’ external transcribed sequences. The variants are known to be differentially expressed during plant development. We…

Continue Reading Low dose ribosomal DNA P-loop mutation affects development and enforces autophagy in Arabidopsis

Pharmaceutics | Free Full-Text | Natural Biopolymer-Based Delivery of CRISPR/Cas9 for Cancer Treatment

Cancer is one of the leading causes of disease-associated mortality, with a rising incidence worldwide [1]. Although many therapeutic methods have been used in cancer treatment, such as chemotherapy, radiotherapy, surgery, and targeted therapy, the overall therapeutic outcome remains unsatisfactory. Therefore, developing new therapeutic means is urgently needed. With advances…

Continue Reading Pharmaceutics | Free Full-Text | Natural Biopolymer-Based Delivery of CRISPR/Cas9 for Cancer Treatment

Development and evaluation of a CRISPR-Cas13a system-based diagnostic for hepatitis E virus

Objectives: Hepatitis E virus (HEV) is the leading cause of acute viral hepatitis worldwide. HEV RNA detection is the gold standard for HEV infection diagnosis and PCR methods are commonly used but are usually time-consuming and expensive, resulting in low detection efficiency and coverage, especially in low-income areas. Here, we…

Continue Reading Development and evaluation of a CRISPR-Cas13a system-based diagnostic for hepatitis E virus

Plug-and-play smart transistor bio-chips implementing point-of-care diagnosis of AMI with modified CRISPR/Cas12a system

. 2024 Feb 15:246:115909. doi: 10.1016/j.bios.2023.115909. Epub 2023 Dec 5. Affiliations Expand Affiliations 1 School of Laboratory Medicine, Hubei University of Chinese Medicine, 16 Huangjia Lake West Road, Wuhan, 430065, PR China; Department of Pharmacy, Renmin Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, PR China. 2 School of Laboratory…

Continue Reading Plug-and-play smart transistor bio-chips implementing point-of-care diagnosis of AMI with modified CRISPR/Cas12a system

Top Biology Professor In Israel For Solidarity Visit

Prof. Eugene Koonin, one of the world’s leading evolutionary biologists, recently visited Israel as a gesture of solidarity and even took the time to volunteer in the Gaza border communities that came under attack on October 7.   Koonin is among the scientists who discovered the CRISPR mechanism, the hallmark…

Continue Reading Top Biology Professor In Israel For Solidarity Visit

Team Leader Bioinformatics – Ryvu Therapeutics, Krakow

Team Leader Bioinformatics – Ryvu Therapeutics, Krakow Team Leader Bioinformatics Ryvu Therapeutics Krakow, Poland As Bioinformatics Team Leader you will be responsible for development of this area within Data Science department which includes managing and growing the team, setting and executing short and long term plans, propagating collaboration with other…

Continue Reading Team Leader Bioinformatics – Ryvu Therapeutics, Krakow

FDA approves two gene therapy treatments for sickle cell disease

Two new gene therapies to treat sickle cell disease were approved by the U.S. Food and Drug Administration Dec. 8. The treatments, both produced by Boston-area companies, join 32 other approved gene therapies and are approved to treat the disease in the United States. Experts say the developments are a…

Continue Reading FDA approves two gene therapy treatments for sickle cell disease

Bioinformatics scientist | GENOMINES

Job Description Who we are Genomines is a young biotechnology company based in Paris and Saclay, specialized in sustainable extraction of Nickel from plants. The mission of Genomines is to usher in a new era of sustainable mining by using genetically enhanced plants to extract metals from soil (agromining). Through…

Continue Reading Bioinformatics scientist | GENOMINES

MAVS found to antagonize human stem cell senescence as a mitochondrial stabilizer

MAVS maintains mitochondrial homeostasis and regulates cellular senescence through stabilizing OPA1. A. Depletion of MAVS accelerates cellular senescence of human mesenchymal stem cells. B. MAVS deficiency compromises mitochondrial dynamics. C. A model illustrating the MAVS-OPA1 axis regulates mitochondrial homeostasis and human stem cell senescence. Credit: Research A recent study led…

Continue Reading MAVS found to antagonize human stem cell senescence as a mitochondrial stabilizer

csi-miR-96-5p delivered by Clonorchis sinensis extracellular vesicles promotes intrahepatic cholangiocarcinoma proliferation and migration via the ferroptosis-related PTEN/SLC7A11/GPX4 axis | Parasites & Vectors

Human tissue samples The preoperative diagnosis of CS mainly relies on stool microscopy, enzyme-linked immunosorbent assay, or endoscopy. Fresh liver and intrahepatic bile duct specimens were collected from ICC patients with (CS-ICC group) and without (NC-ICC group) CS infection during partial hepatectomy at the First Hospital of Jilin University. Tumor tissues…

Continue Reading csi-miR-96-5p delivered by Clonorchis sinensis extracellular vesicles promotes intrahepatic cholangiocarcinoma proliferation and migration via the ferroptosis-related PTEN/SLC7A11/GPX4 axis | Parasites & Vectors

Exploring the Latest Advances in Transcriptomics

Since the idea of genetic regulation was first postulated back in the 1950s, our scientific understanding of the transcriptome has deepened greatly.1 Looking into the transcriptome of cells and tissues has helped scientists to understand the biological processes that drive both health and disease; however, the complex and occasionally mysterious…

Continue Reading Exploring the Latest Advances in Transcriptomics

The top biotech breakthroughs that defined 2023

As we look back at 2023 it is clear that the year has been marked by steady progress and notable breackthroughts in the biotech industry. From advancements in Alzheimer’s disease treatments to new approaches in cancer therapy, artificial intelligence (AI) progression, and obesity management, this year has seen important steps…

Continue Reading The top biotech breakthroughs that defined 2023

Enhancement and inactivation effect of CRISPR/Cas12a via extending hairpin activators for detection of transcription factors

Li Q, Song ZL, Zhang YX, Zhu LN, Yang Q, Liu XF, Sun XF, Chen XX, Kong RM, Fan GC, Luo XL (2023) Synergistic Incorporation of two ssDNA activators enhances the trans-cleavage of CRISPR/Cas12a. Anal Chem 95:8879–8888 Article  CAS  PubMed  Google Scholar  Ma JY, Wang SY, Du YC, Wang DX,…

Continue Reading Enhancement and inactivation effect of CRISPR/Cas12a via extending hairpin activators for detection of transcription factors

Based on CRISPR-Cas13a System, to Establish a Rapid Visual Detection Method for Avian Influenza Viruses

1Hebei Agricultural University, China 2Institute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, China 3Hebei Sanshi Biotechnology Co., Ltd, China The final, formatted version of the article will be published soon. Notify me Receive an email when it…

Continue Reading Based on CRISPR-Cas13a System, to Establish a Rapid Visual Detection Method for Avian Influenza Viruses

Summary of Genomics and Transcriptomics – DNA sequencing I. Goal II. Methodology A. Sanger DNA

DNA sequencing I. Goal II. Methodology A. Sanger DNA sequencing ● Up to 900 base pairs ● Primer extension with labeled ddNTPs (radioactive or fluorescent) ● Prior knowledge on target needed ● Difficult to detect variation in mixtures ● High accuracy + still in use for genotyping When it is…

Continue Reading Summary of Genomics and Transcriptomics – DNA sequencing I. Goal II. Methodology A. Sanger DNA

39.5% below its target price, is this the most exciting growth stock?

Image source: Getty Images On 15 November, the UK medicines regulator approved a therapy that uses the CRISPR–Cas9 gene-editing tool, marking a world first. And it sent shares in this growth stock into hyperdrive. And then on 8 December, the US Food and Drug Administration (FDA) also gave the treatment the…

Continue Reading 39.5% below its target price, is this the most exciting growth stock?

Charles River’s (CRL) Memphis Site Achieves Crucial Approval

Charles River Laboratories International, Inc. CRL recently achieved an important milestone in its strategic collaboration with Vertex Pharmaceuticals to manufacture CASGEVY (exagamglogene autotemcel [exa-cel]). The company’s Memphis facility has been approved to manufacture Vertex’s CASGEVY — the first-ever gene-edited therapy in the world that targets severe sickle cell disease (SCD)….

Continue Reading Charles River’s (CRL) Memphis Site Achieves Crucial Approval

K-State researchers lower gluten content, maintain dough quality in wheat bread

MANHATTAN, Kan. (WIBW) – Kansas State University researchers have recently discovered ways to keep those with gluten allergies safer. Researchers have reported a breakthrough in developing wheat-based foods that contain lower amounts of gluten, a discovery that may lessen the adverse effects for those with celiac or other autoimmune diseases….

Continue Reading K-State researchers lower gluten content, maintain dough quality in wheat bread

Biotechnology Breakthroughs: How Genetic Engineering is Revolutionizing Healthcare

Share Tweet Share Share Email Among the various branches of biotechnology, genetic engineering stands out as a revolutionary field that holds immense potential for transforming healthcare as we know it. This article explores the latest biotechnological breakthroughs, focusing on how genetic engineering is…

Continue Reading Biotechnology Breakthroughs: How Genetic Engineering is Revolutionizing Healthcare

The Next Chapter in Genome Editing? Tome Emerges from Stealth with $213M

Rahul Kakkar, MD, Tome Biosciences president and CEO While the CRISPR community celebrates the recent first FDA approval of a CRISPR-Cas9 therapy (Casgevy), new entities are making strides in their efforts to write perhaps the definitive new chapter in programmable genome editing. Last week, Tome Biosciences—a developer of genome editing…

Continue Reading The Next Chapter in Genome Editing? Tome Emerges from Stealth with $213M

CRISPR/Cas9-mediated nexilin deficiency interferes with cardiac contractile function in zebrafish in vivo

CRISPR/Cas9-induced homozygous knockout of nexn causes progressive cardiac dysfunction without affecting skeletal muscle function in zebrafish Several studies in different animal models and cardiomyopathy patients have shown that loss of NEXN is leading to DCM which is characterized by an impaired contractility of the heart6,10,12. Homozygous loss of NEXN mostly…

Continue Reading CRISPR/Cas9-mediated nexilin deficiency interferes with cardiac contractile function in zebrafish in vivo

Better Growth Stock: Archer Aviation or Prime Medicine? , The Motley Fool

Small-cap stocks are often attractive investments in bullish markets. While a bull market in 2024 is not guaranteed, some small caps are already warming up in anticipation of better economic conditions next year. As a result, it may be a smart move to start adding some select small caps to…

Continue Reading Better Growth Stock: Archer Aviation or Prime Medicine? , The Motley Fool

Viral Vectors and Plasmid DNA Manufacturing market is

Visiongain has published a new report entitled Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034: Forecasts by Vector Type (Adenovirus, Retrovirus, Plasmid DNA, AAV, Lentivirus, Others), by Application (Antisense and RNAi, Gene Therapy, Cell Therapy, Vaccinology), by End-use (Pharma and Biopharma Companies, Research Institutes), by Disease (Oncology, Genetic Disorders,…

Continue Reading Viral Vectors and Plasmid DNA Manufacturing market is

Casgevy, sickle cell gene-editing therapy, favored for EU approval

A European Medicines Agency committee has issued a positive opinion on the gene-editing therapy Casgevy (exagamglogene autotemcel) in treating sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). The Committee for Medicinal Products for Human Use (CHMP) recommendation will be considered by the European Commission in making a final approval decision…

Continue Reading Casgevy, sickle cell gene-editing therapy, favored for EU approval

Tome Biosciences CEO Rahul Kakkar on recent funding round

Tome Biosciences made a splash last week when it emerged from stealth mode with $213 million in funding. The programmable genomic integration (PGI) company based in Watertown, Massachusetts, raised significant financing from investors like Andreessen Horowitz (a16z) Bio + Health, Arch Venture Partners, Fujifilm Corporation and others.  Tome CEO Rahul Kakkar, MD…

Continue Reading Tome Biosciences CEO Rahul Kakkar on recent funding round

HUIADGENE ANNOUNCES RARE PEDIATRIC DRUG DESIGNATION GRANTED TO HG302, A NOVEL CRISPR DNA-EDITING THERAPY, FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

HG302 effectively generates stable genome editing with minimal off-target effects in-vitro and in-vivo A single intravenous injection of HG302 restores functional dystrophin protein expression HG302 demonstrates therapeutic effects by improving muscle functions in humanized DMD mice SHANGHAI and CLINTON, N.J., Dec. 19, 2023 /PRNewswire/ — HuidaGene Therapeutics (辉大基因”HuidaGene”) today announced…

Continue Reading HUIADGENE ANNOUNCES RARE PEDIATRIC DRUG DESIGNATION GRANTED TO HG302, A NOVEL CRISPR DNA-EDITING THERAPY, FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

Apex Systems hiring Scientist II, Bioinformatics, Machine Learning in Watertown, MA

Job#: 1367574Job Description:Scientist II, Bioinformatics, Machine Learning (1367574) Location: Watertown, MA (Onsite) Science: Gene Editing Therapeutic Area: Genetic Diseases Job Overview: Our client is seeking a talented Bioinformatics Data Scientist to join their growing team and play a crucial role in the expansion of their platform. In this role, you…

Continue Reading Apex Systems hiring Scientist II, Bioinformatics, Machine Learning in Watertown, MA

CRISPR and CAS Gene Market Development Status 2029

[New York, November 2023] – A comprehensive market analysis report on the CRISPR and CAS Gene Market has been unveiled by StatsNData and offers valuable insights and information for both industry veterans and newcomers. This in-depth report not only provides revenue forecasts for the CRISPR and CAS Gene market and…

Continue Reading CRISPR and CAS Gene Market Development Status 2029

Solved 33. The coding DNA sequence of a human gene contains

Transcribed image text: 33. The coding DNA sequence of a human gene contains 2001 base pairs. A CRISPR-Cas9 experiment is setting up to knock out this gene in the fibroblast cell lines. It is known that the GC content of the coding sequence of this gene is 60%. In CRISPR-Cas…

Continue Reading Solved 33. The coding DNA sequence of a human gene contains

FDA approved treatments use gene therapy to help patients with sickle cell disease

By Olivia Trani  The U.S. Food and Drug Administration recently approved two gene therapies, Casgevy and Lyfgenia, to treat sickle cell disease in people ages 12 and older. One of the therapies, Casgevy, use a novel gene-editing technique called CRISPR/Cas9, which can modify a cell’s DNA at a targeted location…

Continue Reading FDA approved treatments use gene therapy to help patients with sickle cell disease

Solved R plasmid R determinant CRISPR tracrRNA sgRNA E |||

R plasmid R determinant CRISPR tracrRNA sgRNA E ||| ||| E ||| ||| A gene that induces antibiotic-resistance. Small circle of extragenomic DNA that contains antibiotic resistant genes. Clustered regularly interspaced short palindromic sequences in bacterial that contain repetitive viral information that can be expressed to interfere with viral DNA…

Continue Reading Solved R plasmid R determinant CRISPR tracrRNA sgRNA E |||

Vertex (VRTX), CRISPR Get Positive CHMP Opinion for Gene-Therapy

Vertex Pharmaceuticals Incorporated VRTX announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (“EMA”) had adopted a positive opinion, recommending the conditional approval of Casgevy to treat severe sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). The CHMP’s recommendation, although not legally binding, will…

Continue Reading Vertex (VRTX), CRISPR Get Positive CHMP Opinion for Gene-Therapy

3 Biotech Stocks Most Wall Street Analysts Are Bullish About

The scenario for the biotech industry in 2024 looks upbeat after a challenging ride in 2023. New drug approvals, pipeline development, and an increase in mergers & acquisitions (M&A) activity boosted investor sentiment in the last couple of months, even though an uncertain macroeconomic environment was a headwind. Pharma and…

Continue Reading 3 Biotech Stocks Most Wall Street Analysts Are Bullish About

Global Oligonucleotide Library Market Research Report 2024-2031 | 117 Pages Report

(MENAFN– The Express Wire) Global |117 Pages| Report on “Oligonucleotide Library Market” offers a detailed analysis (2024-2031)which is expected to witness remarkable growth in the coming years. The implementation of new technologies and innovative solutions will drive the market’s revenue generation and increase its market share by 2031 with Revenue…

Continue Reading Global Oligonucleotide Library Market Research Report 2024-2031 | 117 Pages Report

CRISPR and CAS Gene Market

The Market Research report titled CRISPR and CAS Gene Market Report 2023: Exploring Future Opportunities, Emerging Trends, Comprehensive Analysis, and Forecast Till 2029 provides valuable insights into the global CRISPR and CAS Gene market. The report presents detailed information regarding the market size (measured in Million Units for volume and…

Continue Reading CRISPR and CAS Gene Market

CRISPR-Cas12a-Enhanced Mass Spectrometric DNA Nanomachine for HPV-16 Detection in Human Serum

Cervical cancer is the second most harmful cancer to women, while human papillomavirus (HPV)-16 is the main cause of cervical cancer. Early virus screening can reduce the risk of death, but sometimes challenged by the low concentration and complicated matrix in physiological samples such as human serums. Herein, we report…

Continue Reading CRISPR-Cas12a-Enhanced Mass Spectrometric DNA Nanomachine for HPV-16 Detection in Human Serum

Promising Biotech Selling Way Under Cash Value

Nkarta is using CRISPR technology for cell therapies for leukemia. The FDA just approved a similar cell therapy treatment for Vertex using the same CRISPR technology. Nkarta is trading well below cash value and has a significant short position sinking underwater. We did very well with Talaris as a takeover…

Continue Reading Promising Biotech Selling Way Under Cash Value

Programmable Genomic Integration Company Raises Over $200 Million

Tome Biosciences – a programmable genomic integration company – recently announced it has launched to usher in a new era of genomic medicines based on programmable genomic integration (PGI). PGI enables the insertion of any DNA sequence of any size into any programmed genomic location. And the company has raised…

Continue Reading Programmable Genomic Integration Company Raises Over $200 Million

Charles River, Vertex Reach Milestone In Cell Therapy Collaboration

Charles River Laboratories reached a milestone in its strategic collaboration to manufacture CASGEVY (exagamglogene autotemcel [exa-cel]). CASGEVY has been approved in some countries for certain eligible patients. The news follows Charles River’s Memphis center of excellence passing back-to-back audits from both the U.S. FDA and the Health Products Regulatory Authority, on…

Continue Reading Charles River, Vertex Reach Milestone In Cell Therapy Collaboration

Genetic Engineering in Agriculture: Transforming the Future of Farming

In recent years, the field of genetic engineering in agriculture has been rapidly advancing, offering innovative solutions to some of the most pressing challenges in food production. As we look ahead to the period from 2023 to 2030, the global genetic engineering in agriculture market is poised to undergo significant…

Continue Reading Genetic Engineering in Agriculture: Transforming the Future of Farming

Scientists construct a synthetic yeast genome

The yeast genome contains redesigned chromosome sequences that can shed light on the impact of genetic variations on individual traits and potentially be used to reveal the causes of genetic diseases. Chromosomes are long DNA molecules that collectively form a genome, containing all the genetic material of an organism. Advances…

Continue Reading Scientists construct a synthetic yeast genome

CRISPR-Cas9 Gene Editing Service Market Size, Share Evaluate the Key Region Forecasted till 2024-2031

Global CRISPR-Cas9 Gene Editing Service Market” research and analysis play a crucial role in CRISPR-Cas9 Gene Editing Service Market strategies, as businesses seek to discover which CRISPR-Cas9 Gene Editing Services are most relevant and have the highest search volume within their niche. By understanding the CRISPR-Cas9 Gene Editing Service Market,…

Continue Reading CRISPR-Cas9 Gene Editing Service Market Size, Share Evaluate the Key Region Forecasted till 2024-2031

2 Stocks Profiting from Unstoppable Trends That Can Make You Rich The Motley Fool

Sometimes trends are short-term, and as a long-term investor, you probably won’t want to pay too much attention to them. But some trends, because of their potential to change the way things are done for the better, are worth a second look – and even investment. Today, both artificial intelligence…

Continue Reading 2 Stocks Profiting from Unstoppable Trends That Can Make You Rich The Motley Fool

Brace yourselves for these trends in clinical research in 2024

There’s an air of cautious optimism about 2024, after a difficult few years following the end of the pandemic when investment in pharma and biotech research dropped substantially. After this significant reset, there’s now hope that in 2024, in line with emerging trends, the funds will be there for the…

Continue Reading Brace yourselves for these trends in clinical research in 2024

Gene Editor to Treat Blood Diseases

The European Medicines Agency (EMA) has recommended granting conditional marketing authorization for Casgevy (exagamglogene autotemcel) for the treatment of transfusion-dependent beta-thalassemia and severe sickle cell disease in patients 12 years or older who are appropriate candidates for hematopoietic stem cell transplantation but a suitable donor is not available. The treatment…

Continue Reading Gene Editor to Treat Blood Diseases

CHMP recommends gene therapy for beta thalassemia and sickle cell disease

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Vertex Pharmaceuticals and CRISPR Therapeutics’ Casgevy (exagamglogene autotemcel) to treat transfusion-dependent beta thalassemia (TDT) and severe sickle cell disease (SCD). SCD and beta thalassemia are genetic conditions caused by errors in the gene…

Continue Reading CHMP recommends gene therapy for beta thalassemia and sickle cell disease

Sickle cell triumph raises questions

In the realm of genetic manipulation, Crispr technology emerges as a double-edged sword. Enabling precise gene editing, it holds promise for eradicating diseases like sickle cell through treatments like Casgevy. Yet, with the power to shape the very fabric of life, ethical concerns loom large. While some foresee a future…

Continue Reading Sickle cell triumph raises questions

Vertex secures CHMP approval for Casgevy approval in Europe

Casgevy became first FDA-approved medicine to use CRISPR/Cas9 gene-editing technology. Image credit: Shutterstock/Nemes Laszlo. Vertex Pharmaceuticals has gained a positive opinion from the EMA’s CHMP for Casgevy (exa-cel), paving the way for European approval of the sickle cell gene therapy early next year. The CHMP will now send their recommendation…

Continue Reading Vertex secures CHMP approval for Casgevy approval in Europe

Researchers spotlight CRISPR-Cas systems for probiotic engineering

18 Dec 2023 — Researchers from Huazhong Agricultural University in China set out to promote the advancement of probiotic research by reviewing the latest advances and hurdles in CRISPR-Cas systems discovered in microorganisms. They propose a design route for CRISPR systems related to genetically engineered probiotics. While…

Continue Reading Researchers spotlight CRISPR-Cas systems for probiotic engineering

ABL DIAGNOSTICS INTRODUCING CRISPRCHEK – A NEW LINE OF ASSAYS USING THE CRISPR TECHNOLOGY

ABL Diagnostics keeps innovating and developing its Research & Development activities through a new line of PCR detection assays, called CRISPRChek, using the disruptive CRISPR technology. First CRISPRChek prototypes to be focusing on HIV & SARS-CoV-2 detection and quantification. Ambitions to position such innovation as an alternative to current qPCR…

Continue Reading ABL DIAGNOSTICS INTRODUCING CRISPRCHEK – A NEW LINE OF ASSAYS USING THE CRISPR TECHNOLOGY

The Landscape of Agricultural Biotechnology

By 2049, our global population will reach ~9 billion people. Pests, diseases and adverse environmental conditions are impacting crops across the globe, compounding the issue of feeding a growing population. Traditional breeding techniques have enabled scientists and farmers to develop many varieties of plants and livestock tailored for specific agricultural…

Continue Reading The Landscape of Agricultural Biotechnology